One of the most consequential shifts highlighted by the editorial concerns the way scientists fight infection. Conventional antibiotics and antifungals exert strong selective pressure by trying to eliminate pathogens outright, a strategy that inexorably breeds resistance. The emerging alternative is anti-virulence therapy: blocking the molecular machinery pathogens use to cause damage, leaving them alive but harmless. A study by Wang and colleagues illustrates the approach with unusual precision. The researchers identified alcohol dehydrogenase 1, or Adh1, as a previously unrecognized regulator of morphogenesis in Candida albicans, the opportunistic fungus responsible for serious hospital-acquired infections. Adh1 acts through modulation of SNF1 phosphorylation, a signalling step that governs the yeast-to-hypha transition. When the team applied 2-hydroxyanthraquinone, the compound inhibited hyphal formation and biofilm development by targeting this pathway. Because biofilms and invasive hyphae are central to C. albicans virulence, the work opens a route to next-generation antifungals that control pathogenicity rather than survival, easing the evolutionary pressure that drives drug resistance.

A second pillar of the new microbial biotechnology is the engineering of cell factories, the living production lines that manufacture high-value molecules. Here the editorial highlights two studies that push host engineering in different directions. In the first, Yan and colleagues transformed Trichoderma reesei, a filamentous fungus long prized for industrial enzyme production, into a secretory platform for insulin glargine, a mainstay therapeutic for diabetes. Producing therapeutic proteins extracellularly in fungi is notoriously difficult, because misfolded products trigger endoplasmic reticulum stress and degradation. By systematically optimizing secretion signals, fusion partners and the fungus’s ER stress responses, the authors substantially improved recombinant protein secretion, expanding the prospect of filamentous fungi as scalable hosts for pharmaceutical manufacturing. In the second study, Li and colleagues redesigned membrane trafficking pathways in the yeast Saccharomyces cerevisiae to enhance the production of extracellular vesicles. These nanoscale membrane particles are emerging as promising vehicles for drug delivery, and the work establishes generic approaches for their biomanufacture, suggesting a future in which therapeutic delivery systems are grown rather than synthesized.

Parallel to cell factory engineering, protein design is enlarging the catalytic repertoire of microbial enzymes, with direct consequences for sustainable chemistry. Fucosylated oligosaccharides, human milk components with applications in infant nutrition and glycobiology, are difficult to synthesize chemically. Vodičková and colleagues reprogrammed an α-L-fucosidase from the bacterium Paenibacillus thiaminolyticus into an efficient transfucosidase through rational mutagenesis, shifting the enzyme’s catalytic output from hydrolysis, which cleaves bonds, towards transglycosylation, which builds them. The redesigned catalyst enables selective synthesis of valuable fucosylated products and holds potential for biosensor development. In a complementary demonstration of how small changes yield large functional leaps, Kato and colleagues took CYP107J1, a previously uncharacterized cytochrome P450 from Bacillus subtilis, and converted it into a hydrogen peroxide-driven peroxygenase with just two amino acid substitutions. The redesigned enzyme displayed dramatically improved catalytic activity and broadened substrate specificity, including efficient synthesis of indigo, the dye behind classic blue denim. These results echo a broader trend of enzyme bioprospecting through metagenomics, in which unexplored microbial diversity supplies raw catalytic material that protein engineering then refines for industrial use.

Engineering ambition, the editorial argues, is now extending beyond genomes to the manufacturing process itself. Delvenne and colleagues introduced Segregostat, a real-time cell-machine interface that pairs automated flow cytometry with dynamic process control. The platform continuously monitors microbial population structure inside a bioreactor and adjusts operating conditions on the fly, maintaining stable physiological states even under industrially relevant perturbations such as nutrient fluctuations or scaling stresses. This matters because the gap between laboratory performance and industrial robustness remains one of biotechnology’s most persistent bottlenecks. By treating a living culture as a controllable system with real-time feedback, Segregostat points toward intelligent, automated biomanufacturing in which systems biology and digital process control converge to improve scalability and reproducibility.

Agriculture represents another frontier where microbial engineering is challenging chemical orthodoxy. Plant growth-promoting microorganisms and biocontrol agents are at the heart of efforts to replace synthetic fertilizers and pesticides, and the editorial spotlights work by Grace and colleagues who reported the first bacteriophages isolated against the bacteria associated with acute oak decline, a devastating syndrome of European oak trees. The phages effectively inhibited Brennera goodwinii and Gibbsiella quercinencis under laboratory conditions, yet performed only modestly in oak saplings. Far from being a failure, the authors argue, the discrepancy exposes the ecological complexity that any field-deployed biocontrol strategy must navigate, from sap chemistry to microbial community dynamics. The episode also marks the return of phage therapy, a practice pioneered more than a century ago and sidelined by the antibiotic era, now re-emerging as antimicrobial resistance erodes conventional treatments. With resistance crises mounting in both medicine and agriculture, phages may be poised to become stars of biological control, provided ecological understanding keeps pace with microbiological innovation.

Vaccine engineering, meanwhile, has been transformed by the COVID-19 era, which demonstrated that mRNA and recombinant platforms can be developed with unprecedented speed. Byun and colleagues contributed a showcase of converging nanobiotechnology and protein engineering: a recombinant nanoparticle vaccine against West Nile virus built on the cholera toxin B subunit displaying the viral envelope domain III antigen. The nanoparticles elicited strong neutralizing antibody responses while minimizing cross-reactivity with related flaviviruses, a critical safety consideration given the risk that imperfect antibodies can worsen disease in secondary flavivirus infections. The result supports the platform’s promise as a safe, scalable technology for responding to emerging infectious diseases, where rapid, specific and manufacturable vaccines are decisive.

Environmental sustainability remains perhaps the field’s defining challenge, and the editorial presents two complementary visions of microbial solutions. Phale and colleagues offered a systems-level perspective on bacterial biodegradation of aromatic pollutants, arguing that successful bioremediation depends not merely on metabolic pathways but on a coordinated arsenal of traits: environmental sensing, chemotaxis, stress tolerance, substrate transport, regulatory networks and microbial cooperation. Their framing recasts biodegradation as an emergent property of complex microbial communities rather than the work of any single enzyme, a view with practical consequences for designing or enriching cleanup consortia. Taking upcycling a step further, Molpeceres-García and colleagues integrated chemical depolymerization with synthetic biology to turn polyethylene terephthalate waste into biodegradable bioplastics. The process first converts PET into BHET by glycolysis, after which an engineered consortium of Comamonas testosteroni and Pseudomonas putida cooperatively metabolizes the PET-derived intermediates into polyhydroxyalkanoates, valuable biodegradable polymers. By coupling chemical recycling with microbial metabolism, the study sketches a credible route toward a circular plastics economy in which yesterday’s bottles become tomorrow’s compostable materials.

Taken together, these studies describe a discipline in the midst of a profound transformation. Whether the goal is an enzyme that builds rather than breaks, a fungus that secretes medicine, a phage that shields a forest, a nanoparticle vaccine against an emerging virus, or a bacterial duo that eats plastic, the common thread is the deliberate integration of mechanistic biological knowledge with engineering principles. Microbial biotechnology, the editorial concludes, is evolving into a truly engineering-driven science, one capable of delivering scalable solutions for healthcare, agriculture, industrial manufacturing and environmental sustainability. As followers of the field’s own reading habits suggest, the most exciting discoveries are no longer those that explain what microbes do, but those that decide what they will do next.

Subject of Research: Engineering microorganisms and enzymes as platforms for antimicrobial therapy, therapeutic protein production, biocatalysis, vaccines, agriculture and plastic upcycling

Article Title: Microbial Biotechnology at the Frontiers of Innovation: Engineering Solutions for Health, Industry and Sustainability

Article References: Bernal, P., & Ramos, J. L. (2026). Microbial Biotechnology at the Frontiers of Innovation: Engineering Solutions for Health, Industry and Sustainability. Microbial Biotechnology, 19(9), Article e70440. https://doi.org/10.1111/1751-7915.70440

Image Credits: AI Generated

DOI: 10.1111/1751-7915.70440

Keywords: microbial biotechnology, synthetic biology, anti-virulence therapy, Candida albicans, cell factories, protein engineering, biocatalysis, bacteriophage biocontrol, nanoparticle vaccines, bioremediation, PET upcycling, polyhydroxyalkanoates

The Pseudomonas syringae complex is a phylogenetic group comprising at least fifteen bacterial species and more than sixty host-specialized pathovars that collectively cause disease in over 180 plant species, including virtually all economically relevant crops. In highbush blueberry (Vaccinium corymbosum), infections manifest as blight of leafy tissues or cankers of woody tissues, both of which reduce plant health and productivity. Disease development depends on the transition of the bacterium from an epiphytic phase, in which cells remain adhered to plant surfaces, to an endophytic phase involving colonization of internal structures and the release of tissue-destroying virulence factors. Environmental conditions common in British Columbia—cool temperatures, high humidity and frequent precipitation—favour the growth and motility of epiphytic populations and thereby increase the likelihood of endophytic infection, making strategies that reduce surface populations before infection establishes an attractive line of defence.

The economic stakes are considerable. Global blueberry production reached roughly 2.14 billion kilograms in 2024, and Canada is the fourth-largest producer worldwide, accounting for nearly one-sixth of global output. Canadian blueberry exports were valued at approximately CAD $695 million in 2024, representing more than 65 percent of all Canadian fruit exports. Nearly 94 percent of the country’s highbush blueberry production occurs in British Columbia, where conditions favourable to the crop simultaneously favour bacterial growth and dispersal on plant surfaces. Traditional management has relied on copper-based biocides, but this approach damages the natural environment, can stunt plant growth through interference with the rhizosphere microbiome, and has been losing efficacy due to the spread of plasmid-borne copper resistance genes. Mitigation is often limited to the costly and unsustainable practice of pruning or culling infected plants.

Against this backdrop, the research team isolated bacteriophages from wastewater samples and from Pseudomonas syringae complex-infected blueberry plants collected at sites in the lower mainland and Okanagan valley regions, ultimately obtaining nineteen relatively stable phage isolates. Because phage predation by individual phage species is generally restricted to a subset of target strains and readily selects for resistant subpopulations, cocktail formulations of multiple distinct phages are typically employed to expand host range, improve efficacy and forestall resistance. The researchers used a semiquantitative spotting analysis to score infection interactions between each phage and a panel of twenty bacterial strains on a scale from zero to four, then excluded seven isolates—deemed weak specialists—that fell below median thresholds for both the number and strength of interactions. Twelve candidate phages advanced to genomic and functional characterization.

Whole-genome sequencing revealed extensive phylogenomic diversity among the candidates. Three isolates proved to be variants of a species within the genus Unosvirus, three were clonal duplicates belonging to Pifdecavirus, and a further group of four—three clonal and one diverged—may represent a novel species within an as-yet-undefined genus most closely related to Pseudomonas phage QdP_Psa3. The most striking discovery was phage φCB10, a jumbo phage with a genome of approximately 310 kilobases encoding 476 predicted coding sequences, most of them of unknown function. φCB10 was unrelated to the other lineages, most closely resembled Pseudomonas jumbo phage Psa21 at only 53.2 percent genomic similarity, and may represent the founding member of a novel genus. All twelve candidates were predicted to be obligately lytic, and bioinformatic screening found no lysogeny-associated genes, antimicrobial resistance determinants or metal resistance cassettes—characteristics considered indispensable for safe agricultural biocontrol.

Environmental stability assays revealed considerable heterogeneity among isolates. Exposure to ultraviolet radiation for one hour reduced viable titres of all phages, with the severity depending on wavelength: under UV-A at 365 nanometres, relevant to field conditions, only φCB16 fell below the detection limit, whereas UV-C at 254 nanometres drove the titres of most phages below detection. Freezing at −20 degrees Celsius produced a particularly polarizing split along predicted morphology: the three myovirus-like phages lost roughly 1.6 to 3.4 orders of magnitude in titre within a single day and became undetectable after 30 days, while podovirus-like isolates fared substantially better, with φCB02 and φCB05 showing no significant losses over the full month. This partitioning suggests that virion structural properties may broadly influence environmental persistence, a phenomenon the authors say warrants mechanistic investigation. Notably, some isolates appeared more stable at 22 degrees Celsius than at the conventional 4 degrees Celsius storage temperature, raising questions about the universality of phage storage conventions. Prolonged exposure to highly acidic conditions, potentially relevant given that blueberries thrive in soil at pH 4.0 to 5.5, was among the most consistently destabilizing stresses, although most phages retained functionality over biologically relevant timescales.

To quantify antibacterial activity, the team performed planktonic killing assays against eight virulent bacterial strains, summarizing 64 phage-host pairs with a Growth Reduction Coefficient derived from bacterial growth curves. Individual phage performance varied widely and depended strongly on the strain: the jumbo phage φCB10 achieved the highest median coefficient, 0.943, and was the only phage rated as strong across all targeted hosts, while roughly half of all single-phage interactions were deemed poor. The two most effective phages were variously combined with the four least effective to construct eight cocktails of three to five variants. Although cocktails did not significantly outperform individual phages overall, four formulations—φC_A, φC_B, φC_C and φC_D—achieved median coefficients above 0.75 and were rated as strong across the full host panel, and were carried forward to plant-based testing.

The decisive validation used a detached-leaf model in which young Draper-variety leaves were pretreated with phage cocktails and then inoculated with two highly virulent strains. Bacterial densities were substantially reduced in all pretreated leaves. At early timepoints corresponding to maximal bacterial densities in untreated leaves, the four cocktails induced reductions of 4.5 to 5.5 logs against strain B11 and 3.2 to 5.6 logs against strain B04. At the ten-day endpoint, two cocktails pushed B11 below the detection limit, and two others reduced B04 below detection. A variant of the Growth Reduction Coefficient calculated from bacterial density over time rated all four cocktails as strong against B11, with φC_D also strong against B04. Critically, ex planta performance correlated strongly with in vitro performance, suggesting that planktonic killing assays can serve as a useful proxy for more complex validation models in high-throughput screens.

Measurements of phage densities inside the leaves supported the conclusion that bacterial suppression was driven by ongoing lytic replication rather than a single contact-mediated kill. The mean in situ phage-to-bacterium ratio rose rapidly to a peak of roughly 1.8 × 10⁴ for treatments targeting B11 before decaying by day ten, and endpoint phage-to-bacterium ratios correlated positively with overall treatment efficacy. The authors interpret this as evidence that successful biocontrol depends not only on the killing efficiency of individual phages but also on their capacity to persist within the plant environment and maintain productive infections over extended periods.

The study establishes a framework for the systematic identification and evaluation of candidate phages for agricultural biocontrol, while flagging the questions that remain before field deployment. Detached-leaf assays cannot fully recapitulate whole-plant systems, and the authors emphasize the need to reproduce these results in larger-scale studies with intact plants and, ultimately, under field conditions, alongside assessments of any impacts on plant health or the native phyllosphere microbiome. The mechanisms governing phage susceptibility among bacterial strains also remain poorly understood. Meanwhile, φCB10—with its exceptional antibacterial performance, favourable stability, enormous coding capacity and potential to carry accessory functions capable of circumventing bacterial defence systems such as restriction-modification and CRISPR-Cas—stands out as a particularly compelling subject for future investigation, both as a biocontrol candidate and as a window into the biology of underexplored jumbo phages.

Subject of Research: Isolation and evaluation of bacteriophages for biocontrol of Pseudomonas syringae complex populations on highbush blueberry leaves

Article Title: Bacteriophages Control Epiphytic Pseudomonas syringae Populations in Highbush Blueberry Leaves

Article References: Ball, C., Lauman, P., Xu, T., Guy, T., Dadej, K., Richter, R., Lubberts, M., Cross, K., Ren, M., Latchman, S. R., Burlakoti, R., Deng, X., Fong, K., & Wang, S. (2026). Bacteriophages Control Epiphytic Pseudomonas syringae Populations in Highbush Blueberry Leaves. Microbial Biotechnology, 19(9), Article e70438. https://doi.org/10.1111/1751-7915.70438

Image Credits: AI Generated

DOI: 10.1111/1751-7915.70438

Keywords: bacteriophages, phage biocontrol, Pseudomonas syringae complex, highbush blueberry, Vaccinium corymbosum, plant pathology, epiphytic bacteria, jumbo phage, phage cocktails, agricultural biotechnology, British Columbia, leaf blight